Inflammation et hyperplasie bénigne de la prostate : cause ou conséquence ?

Costa, 2004, Hyperplasie bénigne de la prostate (HBP) : prévalence en médecine générale et attitude pratique des médecins généralistes français. Résultats d’une étude réalisée auprès de 17. 953 patients, Prog Urol, 14, 33 Irani, 2004, Comparaison internationale de recommandations pour la prise en charge de l’hypertrophie bénigne de la prostate : utilisation d’un instrument générique validé, Prog Urol, 14, 29 Garraway, 1991, High prevalence of benign prostatic hypertrophy in the community, Lancet, 338, 469, 10.1016/0140-6736(91)90543-X Kok, 2009, Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study, J Urol, 181, 710, 10.1016/j.juro.2008.10.025 Nickel, 2008, The relationship between prostate inflammation and lower urinary tract symptoms: Examination of Baseline Data from the REDUCE Trial, Eur Urol, 54, 1379, 10.1016/j.eururo.2007.11.026 Roehrborn CG, Kaplan SA, Noble WD, Lucia MS, Slawin KM, McVary KT. The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPE: Results from the MTOPS study. AUA Meeting 2005. Kohnen, 1979, Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study, J Urol, 121, 755, 10.1016/S0022-5347(17)56980-3 Nickel, 1999, Asymptomatic inflammation and/or infection in benign prostatic hyperplasia, BJU Int, 84, 976, 10.1046/j.1464-410x.1999.00352.x Bierhoff, 1997, Morphological analogies of fetal prostate stroma and stromal nodules in BPH, Prostate, 31, 234, 10.1002/(SICI)1097-0045(19970601)31:4<234::AID-PROS4>3.0.CO;2-K Di Silverio, 2003, Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis, Eur Urol, 43, 164, 10.1016/S0302-2838(02)00548-1 Robert, 2009, Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis, Prostate, 69, 1774, 10.1002/pros.21027 Theyer, 1992, Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia, Lab Invest, 66, 96 Kramer, 2002, Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation, Prostate, 52, 43, 10.1002/pros.10084 Kramer, 2007, Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?, Eur Urol, 51, 1202, 10.1016/j.eururo.2006.12.011 Nickel, 2008, Inflammation and benign prostatic hyperplasia, Urol Clin North Am, 35, 109, 10.1016/j.ucl.2007.09.012 Kundu, 2008, The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells, Prostate, 68, 223, 10.1002/pros.20710 Konig, 2004, Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer, Prostate, 58, 121, 10.1002/pros.10317 Fujita, 2009, Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia, Prostate, 10.1002/pros.21081 Zhang, 2009, CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis, Cytokine Growth Factor Rev Gorelick, 1988, Quantitative bacterial tissue cultures from 209 prostatectomy specimens: findings and implications, J Urol, 139, 57, 10.1016/S0022-5347(17)42292-0 Hochreiter, 2000, Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction, J Urol, 163, 127, 10.1016/S0022-5347(05)67987-6 Sutcliffe, 2007, Viral infections and lower urinary tract symptoms in the third national health and nutrition examination survey, J Urol, 178, 2181, 10.1016/j.juro.2007.06.041 Ponniah, 2000, PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome, Prostate, 44, 49, 10.1002/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7 Steiner, 2003, Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue, Lab Invest, 83, 1131, 10.1097/01.LAB.0000081388.40145.65 McDowell, 2010, Leukocytic promotion of prostate cellular proliferation, Prostate, 70, 377, 10.1002/pros.21071